These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1662116)

  • 1. An activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogene.
    Longmore GD; Lodish HF
    Cell; 1991 Dec; 67(6):1089-102. PubMed ID: 1662116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene cooperativity in Friend erythroleukemia: erythropoietin receptor activation by the env gene of SFFV leads to transcriptional upregulation of PU.1, independent of SFFV proviral insertion.
    Afrikanova I; Yeh E; Bartos D; Watowich SS; Longmore GD
    Oncogene; 2002 Feb; 21(8):1272-84. PubMed ID: 11850847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation in murine erythropoietin receptor induces erythropoietin-independent erythroid proliferation in vitro, polycythemia in vivo.
    Longmore GD; Pharr P; Lodish HF
    Leukemia; 1992; 6 Suppl 3():130S-134S. PubMed ID: 1318465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
    EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of Friend leukemia virus.
    Ikawa Y
    Leukemia; 1997 Apr; 11 Suppl 3():152-4. PubMed ID: 9209327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unregulated expression of the erythropoietin receptor gene caused by insertion of spleen focus-forming virus long terminal repeat in a murine erythroleukemia cell line.
    Hino M; Tojo A; Misawa Y; Morii H; Takaku F; Shibuya M
    Mol Cell Biol; 1991 Nov; 11(11):5527-33. PubMed ID: 1656233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structurally abnormal erythropoietin receptor gene in a human erythroleukemia cell line.
    Ward JC; Harris KW; Penny LA; Forget BG; Kitamura T; Winkelmann JC
    Exp Hematol; 1992 Mar; 20(3):371-3. PubMed ID: 1314735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ-line deletion of p53 reveals a multistage tumor progression in spi-1/PU.1 transgenic proerythroblasts.
    Scolan EL; Wendling F; Barnache S; Denis N; Tulliez M; Vainchenker W; Moreau-Gachelin F
    Oncogene; 2001 Sep; 20(39):5484-92. PubMed ID: 11571646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus.
    Ben David Y; Prideaux VR; Chow V; Benchimol S; Bernstein A
    Oncogene; 1988 Aug; 3(2):179-85. PubMed ID: 2842714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation.
    Barnache S; Wendling F; Lacombe C; Denis N; Titeux M; Vainchenker W; Moreau-Gachelin F
    Oncogene; 1998 Jun; 16(23):2989-95. PubMed ID: 9662331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
    Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
    EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the JAK1-STAT5 pathway by binding of the Friend virus gp55 glycoprotein to the erythropoietin receptor.
    Yamamura Y; Senda H; Noda M; Ikawa Y
    Leukemia; 1997 Apr; 11 Suppl 3():432-4. PubMed ID: 9209415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression cloning of the murine erythropoietin receptor.
    D'Andrea AD; Lodish HF; Wong GG
    Cell; 1989 Apr; 57(2):277-85. PubMed ID: 2539263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility.
    Subramanian A; Hegde S; Correll PH; Paulson RF
    Leuk Res; 2006 Sep; 30(9):1141-9. PubMed ID: 16527351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spleen focus-forming virus long terminal repeat insertional activation of the murine erythropoietin receptor gene in the T3Cl-2 friend leukemia cell line.
    Lacombe C; Chrétien S; Lemarchandel V; Mayeux P; Roméo PH; Gisselbrecht S; Cartron JP
    J Biol Chem; 1991 Apr; 266(11):6952-6. PubMed ID: 1849897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1.
    Ben-David Y; Giddens EB; Letwin K; Bernstein A
    Genes Dev; 1991 Jun; 5(6):908-18. PubMed ID: 2044959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertional inactivation of the p53 gene during friend leukemia: a new strategy for identifying tumor suppressor genes.
    Ben-David Y; Lavigueur A; Cheong GY; Bernstein A
    New Biol; 1990 Nov; 2(11):1015-23. PubMed ID: 2101628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line.
    Ahmed M; Dusanter-Fourt I; Bernard M; Mayeux P; Hawley RG; Bennardo T; Novault S; Bonnet ML; Gisselbrecht S; Varet B; Turhan AG
    Oncogene; 1998 Jan; 16(4):489-96. PubMed ID: 9484838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation arrest and stromal cell-independent growth of murine erythroleukemia cells are associated with elevated expression of ets-related genes but not with mutation of p53.
    Nibbs RJ; Itoh K; Ostertag W; Harrison PR
    Mol Cell Biol; 1993 Sep; 13(9):5582-92. PubMed ID: 8355701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
    Prasher JM; Elenitoba-Johnson KS; Kelley LL
    Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.